Answers to Parliamentary Questions on Nivel Report on Excess Mortality and COVID Vaccines
Health Officials Respond to Concerns Over COVID-19 Vaccine and Mortality Rates
Washington D.C. – The Department of Health and Human Services has addressed concerns raised by lawmakers regarding a recent study on COVID-19 vaccine efficacy and mortality rates. The study, conducted by the National Institute for Health and Vitality (Nivel), sparked debate after suggesting a potential link between vaccination and increased mortality in certain demographics.
Representative Dekker, a member of the Freedom and Democracy Party, had formally requested clarification from the HHS regarding the Nivel findings. In a statement released today, HHS officials emphasized the importance of relying on robust scientific evidence and stressed the safety and efficacy of COVID-19 vaccines.
“We understand the public’s concerns and want to assure everyone that the safety of Americans remains our top priority,” said a spokesperson for the HHS. “The Nivel study is just one piece of a larger body of research, and its findings require further investigation and analysis.”
The HHS statement highlighted the rigorous testing and approval process that all COVID-19 vaccines underwent before being made available to the public. They also pointed to the overwhelming consensus among medical experts that the benefits of vaccination far outweigh any potential risks.
The HHS pledged to continue monitoring the situation closely and to provide the public with transparent and accurate information about COVID-19 vaccines. They encouraged individuals with questions or concerns to consult with their healthcare providers.
This advancement comes as the nation continues to grapple with the ongoing pandemic and the complexities of vaccine hesitancy. The HHS’s response aims to address public concerns while reaffirming the importance of vaccination in protecting individuals and communities from the virus.
Vaccine Hesitancy: HHS Addresses Concerns Over COVID-19 Vaccine and Mortality Rates
NewsDirect3.com – Following the release of a controversial study by the National Institute for Health and Vitality (Nivel) suggesting a possible link between COVID-19 vaccination and increased mortality in specific demographics, the Department of Health and Human services (HHS) has issued a statement addressing public concerns.
Representative Dekker, a Freedom and Democracy Party member, officially requested clarification from the HHS regarding the Nivel findings. In response, the HHS emphasized the importance of relying on comprehensive scientific evidence and stressed the safety and effectiveness of currently authorized COVID-19 vaccines.
“We understand the publicS concerns and want to assure everyone that the safety of Americans remains our highest priority,” stated an HHS spokesperson. “The Nivel study is just one study within a larger body of research,and its findings require further investigation and analysis.”
The HHS statement highlighted the rigorous testing and approval process undergone by all COVID-19 vaccines before public availability. Officials also pointed to the widespread consensus among medical professionals that the benefits of vaccination significantly outweigh any potential risks.
The HHS pledged to closely monitor the situation and provide the public with transparent and accurate data regarding COVID-19 vaccines. they encouraged individuals with questions or concerns to consult with their healthcare providers.
This development emerges as the nation continues to navigate the ongoing pandemic and the challenges of vaccine hesitancy. The HHS response aims to alleviate public anxieties while reaffirming the crucial role of vaccination in protecting individuals and communities from the virus.